Investor FAQs

  1. Catalent, Inc. was formed in April 2007, when it was acquired by affiliates of The Blackstone Group L.P. Prior to that, it formed the core of the Pharmaceutical Technologies and Services segment of Cardinal Health, Inc

  2. Catalent, Inc.’s common stock began trading on July 31, 2014. The IPO consisted of 42,500,000 shares at $20.50 per share.

  3. Catalent, Inc.’s shares are traded on the New York Exchange (NYSE) under the symbol "CTLT."

  4. Catalent, Inc.’s CUSIP number is 148806102.

  5. 14 Schoolhouse Road
    Somerset, New Jersey 08873
    (732) 537-6200

  6. First quarter: September 30

    Second quarter: December 31

    Third quarter: March 31

    Fourth quarter: June 30

  7. Catalent, Inc.’s independent auditor is Ernst & Young.

  8. You may purchase Catalent, Inc.’s stock through a registered stockbroker.

  9. No. Shares of CTLT can be purchased through a registered or discount stock brokerage firm.

  10. Beneficial stockholders with shares held by a broker in the name of the brokerage house should contact their broker on all administrative matters. If you are a registered stockholder and have questions regarding your account status (e.g. number of shares, missing certificates, address changes, etc.), please contact Catalent, Inc.’s transfer agent.

  11. Catalent, Inc.’s transfer agent is Computershare Trust Company, N.A.

  12. Catalent, Inc. has no current plans to pay dividends on its common stock. Any decision to declare and pay dividends in the future will be made at the sole discretion of Catalent, Inc.’s Board of Directors and will depend on, among other things, Catalent, Inc.’s results of operations, cash requirements, financial condition, contractual restrictions, and other factors that its Board of Directors may deem relevant.

  13. Catalent, Inc. will file periodic reports, including Annual Reports (Form 10-K), Quarterly Reports (Form 10-Q) and Current Reports (Form 8-K) with the Securities and Exchange Commission (SEC). These reports are available on the SEC Filings page. Additionally, Catalent, Inc. will post recent financial information, such as quarterly earnings releases, webcast information, and investor presentations, on the Investors page of its website.

  14. You may sign up to receive this information by clicking here to be added to Catalent’s distribution list.

Investor Contact

Investor Relations Dept
Catalent, Inc.
14 Schoolhouse Road
Somerset, NJ 08873

Phone +1 732 537 6325
Fax +1 732 537 5932
investors@catalent.com

development
With our broad range of expert services, we drive faster, more efficient development timelines and produce better products.
delivery
We are a world leader in drug delivery solutions with a proven track record of helping our customers create better treatments.
supply
As a seamless extension of your supply chain, we offer global integrated manufacturing and packaging solutions.